Vanguard Portfolio Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.5M Buy
3,127,195
+424,563
+16% +$11.9M ﹤0.01% 1552
2026
Q1
$77.1M Buy
+2,702,632
New +$92.2M ﹤0.01% 1530

Other funds holding ATRC

Vanguard Portfolio Management's ATRC Position: Q2 2026 in Review

Vanguard Portfolio Management increased its AtriCure (ATRC) stake by 16% in Q2 2026, buying an estimated $11.9M and bringing the position to 3,127,195 shares worth $87.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Vanguard Portfolio Management first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Vanguard Portfolio Management held 3,127,195 shares of AtriCure worth $87.5M as of Q2 2026.
  • Vanguard Portfolio Management bought 424,563 AtriCure shares in Q2 2026, an estimated $11.9M.
  • AtriCure made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1552 holding.
  • Vanguard Portfolio Management first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
  • 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.